Johnson & Johnson Adds Cancer Warning to Diabetic Foot Gel

June 9, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, June 6 (Reuters) - Johnson & Johnson has added a strong "black box" warning about the risk of dying from cancer to the prescribing instructions for the company's Regranex diabetic foot gel, U.S. regulators said on Friday.

Twitter
LinkedIn
Facebook
Email
Print

Johnson & Johnson Family of Companies